Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
Metaphore Biotechnologies, Inc. is seeking a Sr. Scientist to lead protein expression, purification, and analytical characterization to advance platform development and therapeutic discovery programs.
The role emphasizes mammalian expression, protein biochemistry, and assay development within a fast-paced team environment. You will mentor junior scientists, drive robust systems, and collaborate with Antibody Discovery, Engineering, and Computational Biology to turn design into developable
Metaphore Bio is a generative AI drug design company creating a new class of functional antibodies. We are seeking an accomplished protein scientist and leader to run and continually optimize the engine that turns computationally designed antibodies into well-characterized, developable therapeutic proteins. This is a rare opportunity to pair deep protein biochemistry and antibody purification expertise with a first-in-class AI platform - and to shape how a new modality moves from sequence to drug candidate.
Metaphore Biotechnologies is seeking a highly motivated Sr. Scientist to join our Protein Sciences team within Research and Discovery. This role will focus on protein expression, purification, and analytical characterization in support of platform development and therapeutic discovery programs. The ideal candidate will bring strong hands-on experience with mammalian expression systems, protein biochemistry, and assay development, along with the ability to work independently and collaborate effectively across a multidisciplinary team.
The salary range for this role is $126,000 - $181,500. Compensation for the role will depend on a number of factors, including a candidate's qualifications, skills, competencies, and experience. Metaphore Biotechnologies, Inc. currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Metaphore Biotechnologies, Inc.'s good faith estimate as of the date of publication and may be modified in the future.